{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:44:58Z","timestamp":1775580298453,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Key R&D Program of China","award":["2017YFD0502200"],"award-info":[{"award-number":["2017YFD0502200"]}]},{"DOI":"10.13039\/501100000725","name":"Program for the Beijing Dairy Industry Innovation Team","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.03.020","type":"journal-article","created":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T00:53:20Z","timestamp":1586480000000},"page":"3881-3891","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Recombinant Erns-E2 protein vaccine formulated with MF59 and CPG-ODN promotes T cell immunity against bovine viral diarrhea virus infection"],"prefix":"10.1016","volume":"38","author":[{"given":"Shenghua","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanghui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiawei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renjie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengze","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiufeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaohong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.03.020_b0005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1297-9716-44-32","article-title":"Persistent infections after natural transmission of bovine viral diarrhoea virus from cattle to goats and among goats","volume":"44","author":"Bachofen","year":"2013","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2020.03.020_b0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0378-1135(98)00262-4","article-title":"Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections","volume":"64","author":"Houe","year":"1999","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.020_b0015","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.vetmic.2009.09.022","article-title":"Clinical appearance and pathology of cattle persistently infected with bovine viral diarrhoea virus of different genetic subgroups","volume":"141","author":"Bochofen","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2020.03.020_b0020","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.tvjl.2017.01.005","article-title":"A systematic worldwide review of the direct monetary losses in cattle due to bovine viral diarrhoea virus infection 1","volume":"220","author":"Richter","year":"2017","journal-title":"Veterinary J"},{"issue":"3","key":"10.1016\/j.vaccine.2020.03.020_b0025","doi-asserted-by":"crossref","first-page":"e01776","DOI":"10.1128\/JVI.01776-18","article-title":"Cell-to-cell transmission is the main mechanism supporting bovine viral diarrhea virus spread in cell culture","volume":"93","author":"Merwaiss","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2020.03.020_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S1466252318000129","article-title":"Comparative study in the control of bovine viral diarrhea","volume":"19","author":"Larghi","year":"2018","journal-title":"Animal Health Res Rev"},{"key":"10.1016\/j.vaccine.2020.03.020_b0035","doi-asserted-by":"crossref","first-page":"14420","DOI":"10.1038\/s41598-018-32831-2","article-title":"A meta-analysis of bovine viral diarrhoea virus (BVDV) prevalences in the global cattle population","volume":"8","author":"Scharnb\u00f6ck","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2020.03.020_b0040","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.vaccine.2018.07.054","article-title":"Enhanced immune responses to E2 protein and DNA formulated with ISA 61 VG administered as a DNA prime-protein boost regimen against bovine viral diarrhea virus","volume":"36","author":"Cai","year":"2018","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.03.020_b0045","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2460\/ajvr.70.1.73","article-title":"Evaluation of economic effects and performance of the general cattle population after exposure to cattle persistently infected with bovine viral diarrhea virus in a starter feedlot","volume":"70","author":"Hessman","year":"2009","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2020.03.020_b0050","first-page":"1","article-title":"Epidemiological factors and mitigation measures influencing production losses in cattle due to bovine viral diarrhoea virus infection: A meta-analysis","volume":"00","author":"Pinior","year":"2019","journal-title":"Transboundary Emerg Diseases."},{"key":"10.1016\/j.vaccine.2020.03.020_b0055","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/vr.105354","article-title":"Mapping the global prevalence of bovine viral diarrhoea virus infection and its associated mitigation programmes","volume":"184","author":"Richter","year":"2019","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2020.03.020_b0060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.vaccine.2017.11.030","article-title":"Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines","volume":"36","author":"Cibulski","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.020_b0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1080\/01652176.2007.9695228","article-title":"Bovine viral diarrhoea virus (BVDV) diversity and vaccination. a review","volume":"29","author":"Kalaycioglu","year":"2007","journal-title":"Veterinary Quart"},{"key":"10.1016\/j.vaccine.2020.03.020_b0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cvfa.2003.11.001","article-title":"Evolution of bovine viral diarrhea virus vaccines","volume":"20","author":"Kelling","year":"2004","journal-title":"Veterinary Clin Food Animal Prac"},{"key":"10.1016\/j.vaccine.2020.03.020_b0075","doi-asserted-by":"crossref","first-page":"9972","DOI":"10.1016\/j.biomaterials.2014.08.044","article-title":"Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein","volume":"35","author":"Mody","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2020.03.020_b0080","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11259-012-9526-x","article-title":"Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle","volume":"36","author":"Pecora","year":"2012","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2020.03.020_b0085","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1016\/j.vaccine.2018.06.019","article-title":"Comparative analysis of adaptive immune responses following experimental infections of cattle with bovine viral diarrhoea virus-1 and an Asiatic atypical ruminant pestivirus","volume":"36","author":"Riitho","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.020_b0090","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1073\/pnas.0400660101","article-title":"The structure of the RNA-dependent RNA polymerase from bovine viral diarrhea virus establishes the role of GTP in de novo initiation","volume":"101","author":"Choi","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2020.03.020_b0095","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.antiviral.2017.10.010","article-title":"Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry","volume":"149","author":"Pascual","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2020.03.020_b0100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jviromet.2015.09.007","article-title":"Construction and immunogenicity of the recombinant Lactobacillus acidophilus pMG36e-E0-LA-5 of bovine viral diarrhea virus","volume":"225","author":"Zhao","year":"2015","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2020.03.020_b0105","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/372503","article-title":"Generation of the bovine viral diarrhea virus e0 protein in transgenic astragalus and its immunogenicity in sika deer","author":"Gao","year":"2014","journal-title":"Evidence-Based Complementray Alternative Med"},{"key":"10.1016\/j.vaccine.2020.03.020_b0110","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1006\/viro.2000.0661","article-title":"Recombinant bovine adenovirus type 3 expressing bovine viral diarrhea virus glycoprotein E2 induces an immune response in cotton rats","volume":"278","author":"Baxi","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.03.020_b0115","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1099\/vir.0.2008\/001792-0","article-title":"Formation of bovine viral diarrhea virus E1\u2013E2 heterodimers is essential for virus entry and depends on charged residues in the transmembrane domains","volume":"89","author":"Ronecker","year":"2008","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2020.03.020_b0120","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1051\/vetres:2007037","article-title":"Sequence-optimised E2 Constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle","volume":"38","author":"Couvreur","year":"2007","journal-title":"Vet Res"},{"issue":"24","key":"10.1016\/j.vaccine.2020.03.020_b0125","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.020_b0130","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1038\/s41467-018-06151-y","article-title":"Augmentation of vaccine-induced humoral and cellular immunity by a physical radiofrequency adjuvant","volume":"9","author":"Cao","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2020.03.020_b0135","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1073\/pnas.0804699105","article-title":"Molecular and cellular signatures of human vaccine adjuvants","volume":"105","author":"Mosca","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2020.03.020_b0140","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.03.020_b0145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm0703-831","article-title":"CpG motifs: the active ingredient in bacterial extracts?","volume":"9","author":"Krieg","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2020.03.020_b0150","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.vaccine.2011.10.093","article-title":"A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging","volume":"30","author":"Asanuma","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.020_b0155","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1016\/j.vaccine.2004.01.058","article-title":"Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine","volume":"22","author":"Cooper","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.020_b0160","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.4049\/jimmunol.1002837","article-title":"A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice","volume":"186","author":"Yoshiko","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2020.03.020_b0165","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.7150\/thno.22056","article-title":"The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide","volume":"8","author":"Lai","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.vaccine.2020.03.020_b0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jviromet.2019.02.001","article-title":"Impact of long-term storage of clinical samples collected from 1996 to 2017 on RT-PCR detection of norovirus","volume":"267","author":"Cannon","year":"2019","journal-title":"J Virol Meth"},{"key":"10.1016\/j.vaccine.2020.03.020_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2019.105507","article-title":"A novel approach for production of an active N-terminally truncated Ulp1 (SUMO protease 1) catalytic domain from Escherichia coli inclusion bodies","volume":"166","author":"Linova","year":"2020","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2020.03.020_b0180","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.virol.2019.08.023","article-title":"p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo","volume":"537","author":"Zhang","year":"2019","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2020.03.020_b0185","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s00705-015-2412-4","article-title":"Experimental infection of mice with bovine viral diarrhea virus","volume":"160","author":"Seong","year":"2015","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2020.03.020_b0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13567-016-0355-8","article-title":"Influence of orally fed a select mixture of Bacillus probiotics on intestinal T-cell migration in weaned MUC4 resistant pigs following Escherichia coli challenge","volume":"47","author":"Yang","year":"2016","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2020.03.020_b0195","first-page":"449","article-title":"Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+\/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy","volume":"18","author":"Torti","year":"2012","journal-title":"Clin Microbiol Infect Official Publicat European Soc Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2020.03.020_b0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.dci.2011.10.009","article-title":"Yeast-surface expressed BVDV E2 protein induces a Th1\/Th2 response in na\u00efve T cells","volume":"37","author":"Patterson","year":"2012","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.vaccine.2020.03.020_b0205","doi-asserted-by":"crossref","first-page":"4226","DOI":"10.1016\/S0264-410X(01)00157-8","article-title":"Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice","volume":"19","author":"Nobiron","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.020_b0210","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.biologicals.2012.07.002","article-title":"Molecular biology of bovine viral diarrhea virus","volume":"41","author":"Neill","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.03.020_b0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biologicals.2012.09.009","article-title":"The impact of BVDV infection on adaptive immunity","volume":"41","author":"Chase","year":"2013","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2020.03.020_b0220","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature01441","article-title":"CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes","volume":"421","author":"Janssen","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.03.020_b0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/imr.12426","article-title":"CD4(+) T-cell help amplifies innate signals for primary CD8(+) T-cell immunity","volume":"272","author":"Bedoui","year":"2016","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2020.03.020_b0230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nri.2015.10","article-title":"The multifaceted role of CD4(+) T cells in CD8(+) T cell memory","volume":"16","author":"Laidlaw","year":"2016","journal-title":"Nat Rev Immunol"},{"issue":"168","key":"10.1016\/j.vaccine.2020.03.020_b0235","first-page":"1212","article-title":"CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide","volume":"2002","author":"Miconnet","year":"1950","journal-title":"J Immunol (Baltimore, Md)"},{"key":"10.1016\/j.vaccine.2020.03.020_b0240","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity","volume":"186","author":"Chu","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2020.03.020_b0245","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1016\/j.vaccine.2014.10.010","article-title":"The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle","volume":"32","author":"Snider","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.03.020_b0250","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/S0264-410X(98)00450-2","article-title":"An experimental multivalent bovine virus diarrhea virus E2 subunit vaccine and two experimental conventionally inactivated vaccines induce partial fetal protection in sheep","volume":"17","author":"Bruschke","year":"1999","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030373X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030373X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:44:02Z","timestamp":1759401842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2030373X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":50,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X2030373X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.020","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant Erns-E2 protein vaccine formulated with MF59 and CPG-ODN promotes T cell immunity against bovine viral diarrhea virus infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.03.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}